Xstim
Private Company
Funding information not available
Overview
Xstim is a private medical device company commercializing a novel, FDA-approved bone growth stimulator for lumbar spinal fusion. Its portable device leverages clinically proven capacitive coupling technology to deliver low-level electrical pulses, upregulating bone morphogenetic proteins (BMPs) to enhance the body's natural healing process, with cited success rates up to 85%. Founded in 2015, the company targets the significant and growing market of spinal fusion surgeries by offering a patient-centric, take-anywhere therapeutic aid designed to improve fusion success and patient recovery.
Technology Platform
Capacitive Coupling (CC) electrical stimulation platform that delivers targeted, low-level electrical pulses transcutaneously to upregulate bone morphogenetic proteins (BMPs) and enhance the body's natural bone healing process.
Opportunities
Risk Factors
Competitive Landscape
Xstim competes in the bone growth stimulation market, which includes companies offering PEMF (Pulsed Electromagnetic Field), capacitive coupling, and direct current devices. Major competitors include Orthofix (with its Cervical-Stim and Spinal-Stim lines), Bioventus (the Exogen ultrasound system), and older CC devices. Xstim's primary competitive angles are the clinical pedigree of its specific signal, its modern portable design, and a direct-to-patient marketing message.